Author

Carboni Jm

Observed names: J M Carboni, JM Carboni

Institutions: Mayo Clinic, Bristol-Myers Squibb (United States)

Observed institutions: Mayo Clinic, Bristol-Myers Squibb (United States)

OpenAlex ID: A5020211565

Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.

1995 · V Manne, N Yan, et al. · PubMed · 131

Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.

1995 · J M Carboni, N Yan, et al. · PubMed · 63

Taxol and lipopolysaccharide activation of a murine macrophage cell line and induction of similar tyrosine phosphoproteins.

1993 · J M Carboni, C Singh, et al. · PubMed · 26

CD14 dependent and independent signaling pathways in murine macrophages from normal and CD14 "knockout" (CD14KO) mice stimulated with LPS or taxol.

1998 · S N Vogel, P Y Perera, et al. · PubMed · 16

Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.

2009 · P Haluska, JM Carboni, et al. · Cancer Research · 3

Regulation of lymphocyte responses in vitro. VI. -Potentiation of the response to phytohemagglutinin by cytochalasin B.

1976 · D P Bernard, J M Carboni, et al. · PubMed · 3

P2-11-11: IGFBP Ratio Confers Resistance to IGF Targeting and Correlates with Increased Invasion and Poor Outcome in Breast Tumors.

2011 · MA Becker, X Hou, et al. · Cancer Research · 2

Works count: 7

Citation count: 244

H-index: 4

I10-index: 4